The Patent Finder

Anti-Human OX40L Antibodies

Kymab Limited

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 9 of these applications claim priority to application PCT/GB2015/050614, filed Mar 3, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,512,229Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD
In force
 · High confidence
Kymab LimitedIn force
High confidence
US 9,587,030Anti-hOX40L Antibodies, Uses, & Methods
In force
 · High confidence
Kymab LimitedIn force
High confidence
US 9,868,789Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD
In force
 · High confidence
Kymab LimitedIn force
High confidence
US 9,868,790Synergistic Combinations of OX40L Antibodies for the Treatment of GVHD
In force
 · High confidence
Kymab LimitedIn force
High confidence
US 10,654,935Methods of Treating Sle with ANTI-OX40L Antibodies
In force
 · High confidence
Kymab LimitedIn force
High confidence
US 10,669,342ANTI-OX40L Antibodies and Methods of Treating Graft Versus Host Disease
In force
 · High confidence
Kymab LimitedIn force
High confidence
US 11,396,550Methods of Treating Comprising Administering ANTI-OX40L Antibodies
In force
 · High confidence
Kymab LimitedIn force
High confidence
US 11,753,479Nucleic Acids Encoding ANTI-OX40L Antibodies
In force
 · High confidence
Kymab LimitedIn force
High confidence
US 11,773,175Antibodies, Uses & Methods
In force
 · High confidence
Kymab LimitedIn force
High confidence
US RE50,880Anti-Human OX40L Antibodies and Methods of Treatment
In force
 · Low confidence
Kymab LimitedIn force
Low confidence
9 more patents in this group · Pro
10 of 19 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 19, including 1 expired.
Upgrade to Pro
12 of these are in force and held by Kymab Limited.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited